BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serfaty L, Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab. 2008;34:634-637. [PMID: 19195623 DOI: 10.1016/s1262-3636(08)74597-x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Abd El-Kader SM, El-Den Ashmawy EMS. Non-alcoholic fatty liver disease: The diagnosis and management. World J Hepatol 2015; 7(6): 846-858 [PMID: 25937862 DOI: 10.4254/wjh.v7.i6.846] [Cited by in Crossref: 166] [Cited by in F6Publishing: 148] [Article Influence: 23.7] [Reference Citation Analysis]
2 Choung S, Kim JM, Joung KH, Lee ES, Kim HJ, Ku BJ. Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice. PLoS One 2019;14:e0210828. [PMID: 30735525 DOI: 10.1371/journal.pone.0210828] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
3 Albhaisi S, Sanyal AJ. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:665987. [PMID: 34040583 DOI: 10.3389/fendo.2021.665987] [Reference Citation Analysis]
4 Wen X, Wang S, Taveira TH, Akhlaghi F. Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH). PLoS One 2021;16:e0251665. [PMID: 34525124 DOI: 10.1371/journal.pone.0251665] [Reference Citation Analysis]
5 Modares Mousavi SR, Geramizadeh B, Anushiravani A, Ejtehadi F, Anbardar MH, Moini M. Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease. Middle East J Dig Dis 2018;10:90-5. [PMID: 30013757 DOI: 10.15171/mejdd.2018.96] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Duryee MJ, Willis MS, Schaffert CS, Reidelberger RD, Dusad A, Anderson DR, Klassen LW, Thiele GM. Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis. Am J Physiol Gastrointest Liver Physiol 2014;306:G208-17. [PMID: 24284960 DOI: 10.1152/ajpgi.00124.2013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
7 Zain SM, Mohamed R, Mahadeva S, Cheah PL, Rampal S, Basu RC, Mohamed Z. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. Hum Genet. 2012;131:1145-1152. [PMID: 22258181 DOI: 10.1007/s00439-012-1141-y] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 6.4] [Reference Citation Analysis]
8 Lombardi R, Pisano G, Fargion S. Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. Int J Mol Sci. 2016;17:548. [PMID: 27077854 DOI: 10.3390/ijms17040548] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
9 Balkau B, Lange C, Vol S, Fumeron F, Bonnet F. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010;10:56. [PMID: 20529259 DOI: 10.1186/1471-230x-10-56] [Cited by in Crossref: 88] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
10 Lindén D, Ahnmark A, Pingitore P, Ciociola E, Ahlstedt I, Andréasson AC, Sasidharan K, Madeyski-Bengtson K, Zurek M, Mancina RM, Lindblom A, Bjursell M, Böttcher G, Ståhlman M, Bohlooly-Y M, Haynes WG, Carlsson B, Graham M, Lee R, Murray S, Valenti L, Bhanot S, Åkerblad P, Romeo S. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice. Mol Metab 2019;22:49-61. [PMID: 30772256 DOI: 10.1016/j.molmet.2019.01.013] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 24.3] [Reference Citation Analysis]
11 Kim H, Lee DS, An TH, Park HJ, Kim WK, Bae KH, Oh KJ. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. Int J Mol Sci 2021;22:4495. [PMID: 33925827 DOI: 10.3390/ijms22094495] [Reference Citation Analysis]
12 Li H, Guo M, An Z, Meng J, Jiang J, Song J, Wu W. Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China. Int J Environ Res Public Health 2020;17:E1818. [PMID: 32168920 DOI: 10.3390/ijerph17061818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
13 Billeter AT, Müller-Stich BP. [Metabolic surgery]. Chirurg 2019;90:157-70. [PMID: 30734078 DOI: 10.1007/s00104-018-0786-z] [Reference Citation Analysis]
14 Lückhoff HK, Kruger FC, Kotze MJ. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World J Hepatol 2015; 7(9): 1192-1208 [PMID: 26019735 DOI: 10.4254/wjh.v7.i9.1192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Darand M, Alavian SM, Hekmatdoost A. Nigella sativa and Non-Alcoholic Fatty Liver Disease: A Review of the Current Evidence. Hepat Mon 2018;In Press. [DOI: 10.5812/hepatmon.68046] [Reference Citation Analysis]
16 Fracanzani AL, Pisano G, Consonni D, Tiraboschi S, Baragetti A, Bertelli C, Norata GD, Dongiovanni P, Valenti L, Grigore L, Tonella T, Catapano A, Fargion S. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease. PLoS One. 2016;11:e0162473. [PMID: 27627804 DOI: 10.1371/journal.pone.0162473] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
17 Fargion S, Porzio M, Fracanzani AL. Nonalcoholic fatty liver disease and vascular disease: State-of-the-art. World J Gastroenterol 2014; 20(37): 13306-13324 [PMID: 25309067 DOI: 10.3748/wjg.v20.i37.13306] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 116] [Article Influence: 14.8] [Reference Citation Analysis]
18 Asgari-Taee F, Zerafati-Shoae N, Dehghani M, Sadeghi M, Baradaran HR, Jazayeri S. Association of sugar sweetened beverages consumption with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Nutr 2019;58:1759-69. [PMID: 29761318 DOI: 10.1007/s00394-018-1711-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
19 Liu X, Xu J. Body Mass Index and Waistline are Predictors of Survival for Hepatocellular Carcinoma After Hepatectomy. Med Sci Monit 2015;21:2203-9. [PMID: 26223028 DOI: 10.12659/MSM.894202] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Liu Y, Cheng F, Luo Y, Zhan Z, Hu P, Ren H, Tang H, Peng M. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-γ/CD36 Pathway. Biomed Res Int 2017;2017:8234507. [PMID: 28770225 DOI: 10.1155/2017/8234507] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
21 Das B, Das M, Kalita A, Baro MR. The role of Wnt pathway in obesity induced inflammation and diabetes: a review. J Diabetes Metab Disord 2021;20:1871-82. [PMID: 34900830 DOI: 10.1007/s40200-021-00862-8] [Reference Citation Analysis]
22 Maleki I, Aminafshari MR, Taghvaei T, Hosseini V, Rafiei A, Torabizadeh Z, Barzin M, Orang E. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(35): 12566-12573 [PMID: 25253959 DOI: 10.3748/wjg.v20.i35.12566] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
23 Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis. 2014;5:e996. [PMID: 24434519 DOI: 10.1038/cddis.2013.499] [Cited by in Crossref: 165] [Cited by in F6Publishing: 163] [Article Influence: 20.6] [Reference Citation Analysis]
24 Amirinejad A, Totmaj AS, Mardali F, Hekmatdoost A, Emamat H, Safa M, Shidfar F. Administration of hydro-alcoholic extract of spinach improves oxidative stress and inflammation in high-fat diet-induced NAFLD rats. BMC Complement Med Ther 2021;21:221. [PMID: 34479550 DOI: 10.1186/s12906-021-03396-x] [Reference Citation Analysis]
25 Yamada S, Kimura M, Saito Y, Saito H. Nrf2-mediated anti-oxidant effects contribute to suppression of non-alcoholic steatohepatitis-associated hepatocellular carcinoma in murine model. J Clin Biochem Nutr 2018;63:123-8. [PMID: 30279623 DOI: 10.3164/jcbn.17-125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Hajiaghamohammadi AA, Ziaee A, Oveisi S, Masroor H. Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic fatty disease: A randomized controlled pilot study. Hepat Mon. 2012;12:e6099. [PMID: 23087748 DOI: 10.5812/hepatmon.6099] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
27 Guo J, Fang W, Sun L, Lu Y, Dou L, Huang X, Sun M, Pang C, Qu J, Liu G, Li J. Reduced miR-200b and miR-200c expression contributes to abnormal hepatic lipid accumulation by stimulating JUN expression and activating the transcription of srebp1. Oncotarget 2016;7:36207-19. [PMID: 27166182 DOI: 10.18632/oncotarget.9183] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
28 Lung CC, Jian ZH, Huang JY, Nfor ON. Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding. BMC Gastroenterol 2016;16:29. [PMID: 26924648 DOI: 10.1186/s12876-016-0434-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kotronen A, Laaksonen MA, Heliövaara M, Reunanen A, Tuomilehto J, Yki-Järvinen H, Peltonen M, Knekt P. Fatty liver score and 15-year incidence of type 2 diabetes. Hepatol Int 2013;7:610-21. [PMID: 26201794 DOI: 10.1007/s12072-013-9430-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
30 Mazzolini G, Sowa JP, Atorrasagasti C, Kücükoglu Ö, Syn WK, Canbay A. Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence. Cells 2020;9:E2458. [PMID: 33187255 DOI: 10.3390/cells9112458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cantero I, Elorz M, Abete I, Marin BA, Herrero JI, Monreal JI, Benito A, Quiroga J, Martínez A, Huarte MP, Uriz-Otano JI, Tur JA, Kearney J, Martinez JA, Zulet MA. Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults. Int J Med Sci 2019;16:75-83. [PMID: 30662331 DOI: 10.7150/ijms.28044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
32 Gull N, Arshad F, Naikoo GA, Hassan IU, Pedram MZ, Ahmad A, Aljabali AAA, Mishra V, Satija S, Charbe N, Negi P, Goyal R, Serrano-Aroca Á, Al Zoubi MS, El-Tanani M, Tambuwala MM. Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma. J Gastrointest Cancer 2022. [PMID: 35285010 DOI: 10.1007/s12029-022-00809-z] [Reference Citation Analysis]
33 Rizzi L, Braschi M, Colombo M, Vaiana N, Tibolla G, Norata GD, Catapano AL, Romeo S, Prosperi D. Novel biotinylated bile acid amphiphiles: micellar aggregates formation and interaction with hepatocytes. Org Biomol Chem 2011;9:2899-905. [PMID: 21373679 DOI: 10.1039/c0ob00878h] [Reference Citation Analysis]
34 García-Escobar E, Valdés S, Soriguer F, Vendrell J, Urrutia-Etxebarria IM, Maldonado-Araque C, Ortega E, Ocón P, Montanya E, Menéndez E, Lago-Sampedro A, González-Frutos T, Gomis R, Goday A, García-Serrano S, Galán-García JL, Castell C, Bordiú E, Badía R, Aguilera-Venegas G, Girbés J, Gaztambide S, Delgado E, Chaves FJ, Castaño L, Calle-Pascual A, Rojo-Martínez G, Franch-Nadal J. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study. Sci Rep 2021;11:16453. [PMID: 34385479 DOI: 10.1038/s41598-021-95546-x] [Reference Citation Analysis]
35 Lamaziere A, Wolf C, Quinn PJ. Perturbations of lipid metabolism indexed by lipidomic biomarkers. Metabolites. 2012;2:1-18. [PMID: 24957365 DOI: 10.3390/metabo2010001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
36 Yang C, Yang S, Xu W, Zhang J, Fu W, Feng C. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. PLoS One 2017;12:e0177249. [PMID: 28510581 DOI: 10.1371/journal.pone.0177249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
37 Gariani K, Jornayvaz FR. Pathophysiology of NASH in endocrine diseases. Endocr Connect 2021;10:R52-65. [PMID: 33449917 DOI: 10.1530/EC-20-0490] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zhu S, Wu Y, Ye X, Ma L, Qi J, Yu D, Wei Y, Lin G, Ren G, Li D. FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy. Mol Cell Biochem. 2016;420:107-119. [PMID: 27435856 DOI: 10.1007/s11010-016-2774-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
39 Stork BA, Dean A, Ortiz AR, Saha P, Putluri N, Planas-Silva MD, Mahmud I, Rajapakshe K, Coarfa C, Knapp S, Lorenzi PL, Kemp BE, Turk BE, Scott JW, Means AR, York B. Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 Regulates Hepatic Fuel Metabolism. Mol Metab 2022;:101513. [PMID: 35562082 DOI: 10.1016/j.molmet.2022.101513] [Reference Citation Analysis]
40 Stolic RV, Trajkovic GZ, Kostic MM, Sovtic SR, Odalovic AM, Krdzic BD, Sipic MV, Lazic S, Sojevic-Timotijevic ZN. Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients. Int Urol Nephrol 2016;48:883-9. [PMID: 26905407 DOI: 10.1007/s11255-016-1237-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Pontoriero AC, Trinks J, Hulaniuk ML, Caputo M, Fortuny L, Pratx LB, Frías A, Torres O, Nuñez F, Gadano A, Argibay P, Corach D, Flichman D. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations. BMC Genet 2015;16:93. [PMID: 26219465 DOI: 10.1186/s12863-015-0255-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
42 Park J, Lee JM, Lee G, Jeon SK, Joo I. Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques. Korean J Radiol 2022;23:13-29. [PMID: 34983091 DOI: 10.3348/kjr.2021.0112] [Reference Citation Analysis]
43 Ma C, Liu Y, He S, Zeng J, Li P, Ma C, Ping F, Zhang H, Xu L, Li W, Li Y. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels. Front Endocrinol (Lausanne) 2020;11:600472. [PMID: 33329401 DOI: 10.3389/fendo.2020.600472] [Reference Citation Analysis]
44 Balkau B, Lange C, Vol S, Fumeron F, Bonnet F. Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study. BMC Gastroenterol. 2010;10:56. [PMID: 20529259 DOI: 10.1186/1471/230x-10-56] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Tang R, Liu H, Yuan Y, Xie K, Xu P, Liu X, Wen J. Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma. Oncotarget 2017;8:35403-11. [PMID: 28515345 DOI: 10.18632/oncotarget.15893] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
46 Wang K. Molecular mechanisms of hepatic apoptosis. Cell Death Dis 2014;5:e996. [PMID: 24434519 DOI: 10.1038/cddis.2013.499] [Cited by in F6Publishing: 1] [Reference Citation Analysis]